HealthRX.com · Printable medication review sheet
GHK-Cu product and medical-context sheet for a specialist appointment
Fill in the exact product, how it touches your body, and the condition that puts you in a special population, then bring it to the specialist who manages that condition. It records facts for a clinician to interpret; it is not a dose plan.
The product, exactly as labeled
Photograph the label and the lot number before the appointment.
Product name and every word of the label claim
Seller or pharmacy, and lot number
Concentration and other listed ingredients
Sold as a cosmetic or dispensed as a compounded drug?
How it reaches the bodyintact skin, broken skin, after a procedure, microneedling, injection
Reason for using itappearance, wound care, other
Already using it, or only considering it?
Conditions to name at the appointment
- Wilson disease, or a parent, brother or sister with it
- Another liver disease, and how stable it is
- Kidney disease or dialysis
- Pregnant, trying to conceive, or breastfeeding
- Under 18
- Organ transplant, or medicines that suppress the immune system
- HIV or another immune condition
- Cancer now or in the past, and its treatment
Copper, zinc and immune-related medicines you take
| Name | What it is for | Who prescribed it | Since when |
|---|---|---|---|
What the sources on this page establish
- FDA: compounded injectable GHK-Cu may carry a risk of immune reactions from aggregation and peptide-related impurities, and human data to judge its safety are limited.[1]
- NIDDK: people with Wilson disease need lifelong treatment; chelating medicines remove copper and zinc keeps the intestines from absorbing it.[2]
- The registered GHK-Cu gel trial enrolls adults aged 18 to 55 and excludes pregnancy, breastfeeding and recent immunosuppressant use.[3]
- In a randomized trial with 86 evaluable patients with venous stasis ulcers, a tripeptide copper complex cream (the abstract does not name GHK-Cu) did no better than placebo.[4]
Questions for the specialist
- Does my condition change how my body would handle copper from this product, by this route?
- Is there any study of this product in people with my condition, or only in healthy adults?
- Should my transplant, obstetric, kidney or cancer team also see this label?
- Which symptoms would mean I should contact you before using it again?
Sources for the facts on this sheet
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed 2026-10-19. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- National Institute of Diabetes and Digestive and Kidney Diseases. Treatment of Wilson Disease. Accessed 2026-10-19. https://www.niddk.nih.gov/health-information/liver-disease/wilson-disease/treatment
- U.S. National Library of Medicine, ClinicalTrials.gov (API v2 record). NCT07437586: A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Split-Wound Study of Topical GHK-Cu (Copper(II)-Peptide Complex) Gel to Accelerate Re-Epithelialization of Standardized Acute Skin Wounds in Healthy Adults. Accessed 2026-10-19. https://clinicaltrials.gov/api/v2/studies/NCT07437586
- Bishop JB, Phillips LG, Mustoe TA, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 1992. PMID 1495150. https://pubmed.ncbi.nlm.nih.gov/1495150/
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.